Celldex Therapeutics (CLDX) Fails to deliver data

Key failure to deliver metrics for Celldex Therapeutics:

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: S$0.65 M
• Last 3 months FTD volume: S$2.66 M
• Last year FTD volume: S$2.66 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Celldex Therapeutics (CLDX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Celldex Therapeutics (CLDX) - since 2019

Celldex Therapeutics (CLDX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Seagen SGEN	N/A	S$3.02 M	🇺🇸 USA
Agenus AGEN	N/A	S$0.7 M	🇺🇸 USA
Emergent BioSolutions EBS	S$1.19 M	S$6.21 M	🇺🇸 USA
Amgen AMGN	S$97.9 M	S$0.29 B	🇺🇸 USA
Pfizer PFE	S$32.79 M	S$0.34 B	🇺🇸 USA
GlaxoSmithKline GSK	S$0.18 B	S$0.27 B	🇬🇧 UK
Titan Pharmaceuticals TTNP	S$0.1 M	S$1.3 M	🇺🇸 USA